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Abstract 
Objective: The first aim of this study was to assess the proportion of patients who achieved reliable and 
clinically significant change over the course of treatment in an inpatient psychosocial rehabilitation 
program. The second aim was to determine whether age, gender, length of stay, and diagnosis and co-
morbid diagnosis predicted those who were classified as improved or not improved, using clinical 
significance criteria. Method: Three hundred and thirty-seven patients from inpatient units at Bloomfield 
Hospital, Orange, New South Wales, Australia were assessed at admission, 3-month reviews and 
discharge using the expanded Brief Psychiatric Rating Scale, the Health of the Nation Outcome Scales 
and the Kessler 10. Results: Reliable and clinically significant improvement was found for 32.4% of 
inpatients on psychiatric symptomatology, 19.5% on psychosocial functioning and 20.2% on 
psychological distress. Logistic regression analyses found that the predictor variables collectively 
predicted those who made reliable and clinically significant improvement on psychiatric symptomatology, 
but not on psychosocial functioning or psychological distress. Those with a primary diagnosis of 
schizoaffective disorder had higher rates of improvement in psychiatric symptomatology compared to 
those with a diagnosis of schizophrenia. Those with co-morbid substance abuse disorders showed a 
trend towards greater improvement. Conclusions: Inpatient treatment is associated with clinically 
significant improvements for some patients with a severe mental illness. Patients with schizo-affective 
disorders are proportionally more likely to make improvement. 
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Objective: The first aim of this study was to assess the proportion of patients who 
achieved reliable and clinically significant change over the course of treatment in an 
inpatient psychosocial rehabilitation program. The second aim was to determine 
whether age, gender, length of stay and diagnoses predicted those who were classified 
as improved or not improved, using clinical significance criteria.   
Method: Three hundred and thirty-seven patients from inpatient units at Bloomfield 
Hospital, Orange, New South Wales, were assessed at admission, 3 month reviews and 
discharge using the expanded Brief Psychiatric Rating Scale, the Health of the Nation 
Outcome Scales, and the Kessler-10.  
Results: Reliable and clinically significant improvement was found for 32.4% of 
inpatients on psychiatric symptomatology, 19.5% on psychosocial functioning, and 
20.2% on psychological distress. Logistic regression analyses found that the predictor 
variables collectively predicted those that made reliable and clinically significant 
improvement on psychiatric symptomatology, but not on psychosocial functioning or 
psychological distress. Those with a primary diagnosis of schizoaffective disorder had 
higher rates of improvement in psychiatric symptomatology compared to those with a 
diagnosis of schizophrenia. Those with comorbid substance abuse disorders showed a 
trend toward greater improvement.  
Conclusions: Inpatient treatment is associated with clinically significant improvements 
for some patients with a severe mental illness and those with schizoaffective disorders 
are proportionally more likely to make improvement.  
Key words: inpatient, clinical significance, severe mental illness, comorbidity 
  




Severe and persistent mental illnesses are debilitating for the individual and 
financially costly for the community (Access Economics, 2002), but there is 
considerable support for the benefits of psychosocial interventions to improve a range 
of client outcomes (Huxley et al., 2000; Kurtz and Mueser, 2008). Statistical 
significance and effect size statistics have frequently been used to describe outcome. 
However, more recently the usefulness of reporting clinical significance is being 
recognised (Johnson et al., 2006; Lambert and Ogles, 2009). This is because in contrast 
to these other methods, clinical significance identifies differences in treatment outcome 
for individuals (rather than groups) and provides an indication of whether this change is 
clinically meaningful. Whilst multiple methods of measuring clinical significance exist, 
the Jacobson and Truax’s (1991) method seems particularly useful for measuring 
effectiveness of inpatient programs as it examines whether an individual’s change in 
their post-treatment score is a reliable change (i.e. unlikely to be attributable to 
measurement error) and whether the post-treatment score reflects a move from the 
dysfunctional population to a score more typical of a functional population.  
Whilst a number of studies have used clinical significance methods to measure 
treatment effectiveness (Bowersox et al., 2009; Glick et al., 1993) only a limited 
number of studies have examined this within a psychiatric inpatient population and 
report calculated estimates of reliable and clinically significant (RCS) change (e.g., 
Murugesanet al., 2007; Newnham et al., 2007;). 
Murugesan et al., (2007) used clinical significance methods to assess outcomes 
for people with a schizophrenia spectrum disorder attending a medium length-of-stay 
psychosocial rehabilitation program in Australia.  RCS improvement was made by 33% 
of patients on psychiatric symptomatology, 39% on psychosocial functioning and 21% 




on psychological distress. Murugesan et al., (2007) focused on those with schizophrenia 
spectrum disorders, but the units treated patients with a range of other diagnoses and 
psychiatric comorbidity. The sample size was not sufficiently large to allow 
identification of potential predictors of RCS improvement. For example, people with 
comorbid substance abuse in addition to their Axis I diagnosis have been found to be 
more difficult to treat and have poorer outcomes (Grella and Stein, 2006) making 
comorbidity a potential predictor. 
The current study aims to determine the percentage of individuals who show 
RCS improvement at the time of discharge from an inpatient rehabilitation program. 
Whilst research has examined predictors of outcome among patients with a 
schizophrenia spectrum disorder (e.g., Schennach-Wolff et al., 2009), no study appears 
to have examined demographic and clinical predictors of treatment outcome, for 
psychiatric inpatients with predominantly a schizophrenia spectrum disorder, using 
clinical significance criteria to measure outcome. Identification of predictors of RCS 
change has various benefits such as the potential to assist with refining treatment. Given 
this, the second aim of this study is to explore whether age, gender, length of stay, 
diagnosis and comorbid diagnosis predict whether patients show RCS improvements or 
not.  
Method 
Setting and program description 
Data were collected from a medium length of stay inpatient rehabilitation 
facility (Bloomfield Hospital in Orange, New South Wales). Participants attended either 
the 16 bed male or 16 bed female inpatient unit. The mental health team involved in the 
program includes a psychiatrist, psychologist, social worker, diversional therapists, an 




occupational therapist, clinical nurse consultant, manager and nursing staff for each 
unit. Patients are encouraged to attend groups relevant to them on topics such as drug 
and alcohol, medication education or anger management. Care plans are tailored to each 
patient. Discharge is planned except on those rare occasions where a patient manages to 
abscond.  
Admission criteria 
Admission criteria for entry into the program remained unchanged since the 
previous study (Murugesan et al., 2007). The criteria included a DSM-IV disorder but 
excluded individuals with a primary diagnosis of dementia, delirium, substance abuse, 
or developmental disorder. Patients who had secondary diagnoses of substance abuse 
were admitted. Patients were excluded if they were in an acute phase of their illness 
with florid symptoms, and/or those who had an acute physical illness requiring high 
levels of nursing care or intensive medical management. Patients who were frequently 
aggressive or showed other antisocial behaviours were also excluded. The majority of 
patients were involuntarily admitted. The principal reason for admission was for 
psychosocial rehabilitation. Patients were frequently admitted for the purposes of 
improving their medication adherence and reducing substance abuse.  
Participants 
The potential participant pool consisted of 371 consecutive patients 18 years and 
older who were admitted and discharged between November 2003 and November 2008.  
This was a separate group to those previously reported by Murugesan et al., (2007)  in 
the same programs.  
Individuals were excluded from the study if; (a) it was their second admission 
during the study period, then data from their second admission were excluded (8 




patients) or (b) admission or discharge data were missing, so change across time could 
not be calculated (26 patients). This provided a 91% participation rate overall (n = 337). 
There were 170 patients admitted to the male unit and 167 patients admitted to 
the female unit over the study period. The mean age at admission of the male 
participants was 33.7 years (SD = 9.2 years), with a range of 18-61 years. The mean age 
at admission of the female participants was 33.4 years (SD = 10.3 years) with a range of 
18-59 years. The mean length of stay for male participants was 109 days, (SD = 61, 
range 6-397 days). The mean length of stay for female participants was 113 days (SD = 
84, range 15-602 days). Of these female patients, only 4 stayed more than 400 days. The 
mean length of stay for the full sample was 111 days (SD = 73 days, median = 91 days).     
 Patient diagnoses were extracted from medical records. The majority of patients 
had a primary diagnosis of schizophrenia (68.0%, n = 229). Schizoaffective disorder 
was the next most common diagnosis (20.8%, n = 70). Some patients had another 
disorder involving psychosis (6.8%, n = 23). The rest of patients had other diagnoses 
(4.5%, n = 15) such as a personality disorder, depression and substance use disorder.  
Calculations of comorbid diagnoses revealed 38.0% (n = 128) of patients had a 
secondary diagnosis of substance use disorder, 6.5% (n = 22) had an alternative 
comorbid disorder and 55.5% (n = 187) had no comorbid diagnosis.  
Measures 
The measures used in the current study are routinely administered as part of the 
national outcome assessment protocols in mental health by the hospital. They are used 
for the purposes of planning and monitoring patient care as well as measuring outcome. 
Patients have the right to refuse to complete any specific measures.  




The effectiveness of the program was assessed by comparing patient admission 
and discharge scores on the measures. These measures were the same as those used in 
the study by Murugesan et al., (2007) and are as follows: The Expanded version of the 
Brief Psychiatric Rating Scale (BPRS-E; Lukoff et al., 1986), Health of the Nation 
Outcome Scales (HoNOS; Wing et al., 1998), and Kessler-10 (K-10; Kessler et al., 
2002).  
The BPRS-E is a 24 item measure of psychiatric symptomatology which 
involves a structured interview process. It can be divided into four subscales: thought 
disturbance, anergia, affect, and disorganisation (Lukoff, et al., 1986). Items are scored 
on a rating scale from 1 (not present) to 7 (extremely severe) and then a total score is 
calculated. The BPRS-E has good interrater reliability (Ventura et al., 1993).  
The HoNOS is a clinician completed 12-item measure of psychosocial 
functioning. It covers four domains: behavior (e.g. aggression), impairment (e.g. 
cognitive dysfunction), symptoms (e.g. hallucinations), and social functioning (includes 
problems with relationships and living conditions) (Wing et al., 1998). Scores for each 
item range from 0 (no problem) to 4 (severe to very severe problem). The HoNOS has 
good reliability, with an internal consistency of 0.75 (Trauer 1999).  
The K-10 is a 10-item self report measure of psychological symptom distress 
(Kessler et al., 2003). Respondents are asked “in the past 30 days about how often did 
you feel...” various symptoms (e.g. “depressed” and “nervous”). Respondents rate each 
item on a 5-point Likert scale which ranges from “none of the time” to “all of the time”. 
The K-10 has satisfactory internal reliability as measured by Cronbach alpha (α = .93) 
(Kessler et al., 2003). 
Procedure 




The research received ethical review and approval from the University of 
Wollongong Human Research Ethics Committee. Outcome measures were administered 
at admission, discharge and 3 month reviews. The HoNOS was administered by nursing 
staff. The K-10 was completed by the patients. Psychologists working at both units 
administered the BPRS-E.  
Where there was some missing data but over 50% of the scale items were 
completed, a prorated score was calculated (proportional average of the available 
items). Where less than 50% of items were completed for any measure, this data were 
excluded from the analyses. This resulted in six cases being excluded.  
Analytic Strategy 
Paired samples t-tests determined statistically significant changes over time. 
Consistent with the previous study (Murugesan et al., 2007), where discharge data were 
not available, scores from the most recent review prior to discharge were used instead. 
Means and standard deviations were calculated for admission and review/discharge total 
scores on each measure.  
Jacobson and Truax’s method was used to calculate clinically significant 
change. This method involves calculating reliable change indices using the Christensen 
and Mendoza (1986) formula: Reliable Change Index (RCI) = 1.96 × SEdiff.  
According to the Jacobson and Truax method, for reliable change to occur, a 
patient’s difference in total score from admission to discharge had to be equal to or 
greater than the RCI. The SE of measurement of a difference is calculated as: SEdiff = 
SD1 × √2  × �(1 − α), where SD1 is the standard deviation of the admission total and α 
is Cronbach’s coefficient. Percentages that make reliable change (improvement or 
deterioration) were calculated using these methods. To calculate clinical change, three 




different cut-off points needed to be calculated. Clinical change is said to occur if an 
individual’s post-treatment score meets the following cut off criteria:  
Cut-off 1: More than two standard deviations away from the  
      dysfunctional population mean. 
Cut-off 2: Within two standard deviations of the functional  
                  population mean.  
Cut-off 3: Closer to the functional population mean than the dysfunctional  
                              population mean.  
Clinical significance cut-off scores were calculated for the three outcome 
measures, using the Jacobson and Truax’s (1991) methods. Cut-off 2 and 3 were the 
most appropriate for the current sample and enabled comparisons with Murugesan et al., 
(2007). The following formula was used to calculate Cut-off 3:   
Cut-off 3=
(meanclin × SDnorm)+ (meannorm × SDclin)
(SDnorm + SDclin)
 
Meanclin and meannorm  are the mean scores of the dysfunctional population, and the 
functional population (SD is standard deviation). 
A more functional population was considered to be a group with similar 
diagnostic characteristics who were able to reside in the community. Functional 
population normative data for the BPRS-E were taken from a study which included 43 
patients from a community mental health centre and outpatient clinic (Janssen, 
Krabbendam et al., 2003). Functional population normative data for the HoNOS were 
taken from a study which included a subclinical sample of 1669 patients that came into 
contact with a community mental health service (Parabiaghi et al., 2005). Patients were 
considered subclinical if they had a score <2 for all HoNOS items. Normative data used 
for the BPRS-E and HoNOS were the same as the previous study by Murugesan et al., 




(2007). For the K-10, normative data from a large representative sample (n = 10641) of 
individuals living in the Australian community were used (Andrews and Slade, 2001).  
Following calculations of clinically significant improvement, binomial logistic 
regression analyses were then conducted using the outcome measures, with the 
dichotomous dependent variables of “Reliable and Clinically significantly improved” 
versus “Not improved”. Those in the “Not improved” category included those who 
made no change and the few patients who also had reliable and clinically significant 
deterioration. Patients who were asymptomatic at baseline were not included in 
regression analyses since they were by definition not able to make clinically significant 
improvement (Bowersox et al., 2009). Age, gender (treatment unit), length of stay, 
primary diagnosis and comorbid diagnosis were provided for each patient and 
comprised the independent variables.  
 Since the goal was to predict those that showed RCS improvement we chose cut-
off points that produced the largest proportion of improved participants. This was cut-
off 2 for the BPRS-E and HoNOS and cut-off 3 for the K10. Primary diagnosis was 
categorised into three groups: schizophrenia, schizoaffective disorder, other diagnoses. 
Comorbid diagnosis was comprised of three groups, “no comorbid diagnosis”, those 
with a secondary diagnosis of substance use disorder (drug and/or alcohol), and “other 
comorbid disorders”.  
Results 
Statistical significance analyses 
Paired sample t-tests were computed, comparing means of admission and 
discharge scores for all outcome measures (see Table 1). Across all three measures, 
overall patients demonstrated significant improvement. There were variations in sample 




sizes for the different outcome measures. The main reason the BPRS-E was not 
completed was due to the unavailability of the psychologist to conduct interviews at the 
appropriate time.  For the HoNOS, noncompletion was due to being overlooked by 
staff. For the K-10, this was due to patient refusal.  
Insert Table 1 here 
Predicting Reliable and Clinically Significant (RCS) change 
Psychiatric symptomatology (BPRS-E) 
 There were 173 complete admission and discharge datasets available for analysis 
for the BPRS-E. The RCI was 17.8, which was rounded so that an 18 point change 
reflected that reliable change had occurred at the 95% confidence level. Based on this, 
84 patients (48.6%) were designated as reliably improved and no patients showed 
reliable deterioration. The remaining participants showed no reliable change.  
The BPRS-E normative sample mean was 39. Cut-off 2 was calculated as 59. 
RCS improvement was made for 62 patients (35.8%). Cut-off 3 was calculated as 52. 
RCS improvement was made for 56 patients (32.4%). No patient showed RCS 
deterioration, regardless of the cut-off method used.  
For the logistic regression Cut-off 2 was selected and the following groups were 
obtained: those that made RCS improvement (n = 62) and those that did not (n = 67) 
(asymptomatic patients were not included in logistic regressions). The full model 
containing all predictors was statistically significant, χ2(n =129) = 19.7, df = 7, p < .05. 
The model accounted for 18.9% (Nagelkerke R2) of the total variance, and correctly 
classified 69.0% of cases (74.6% correctly classified as no RCS improvement, 62.9% 
correctly classified as making RCS improvement). The estimates of the effects of the 
predictor variables calculated from the regression are summarized in Table 2. Primary 




diagnosis was a significant predictor and comorbid diagnosis approached significance. 
For primary diagnosis, schizophrenia was the reference since this was the most frequent 
diagnosis. Those with schizoaffective disorder were 3.5 times more likely to be in the 
improved group compared to those with a primary diagnosis of schizophrenia, Exp(β) = 
3.52. Although, comorbid diagnosis only approached significance, it suggested that 
those with comorbid substance abuse disorders were over two times more likely to be in 
the improved group, Exp(β) = 2.29. 
In order to check for potential differences between those included in the analysis 
(n = 173) and those who did not have pre-post BPRS-E measures (n = 164) we 
compared the groups using a series of Chi-square tests. There were no significant 
differences between the groups for gender, age, or comorbid diagnosis (p > .05). There 
was a significant difference for primary diagnosis, X2(2, N= 337) = 7.18, p < .05. The 
only difference was between those with a diagnosis of schizophrenia versus 
schizoaffective disorder with a smaller proportion of those included in the analysis 
having a diagnosis of schizoaffective disorder (41%) than those excluded from the 
analysis (59%), X2(1, N=299) = 4.78, p < .05. 
Insert Table 2 about here 
Psychosocial functioning (HoNOS) 
There were 329 complete admission and discharge datasets available for analysis 
for the HoNOS. The RCI for the HoNOS was 10.12 (rounded to 10). Using this RCI a 
total of 100 patients (30.4%) made reliable improvement and three patients (.9%) 
reliably deteriorated. The remaining participants showed no reliable change. Cut-off 2 
was calculated as 6. RCS improvement was made by 75 patients (22.8%). One patient 




made RCS deterioration. Using Cut-off 3 (score of 5), RCS improvement was made by 
64 patients (19.5%). One patient made RCS deterioration.  
Cut-off 2 was selected for the logistic regression and the following groups were 
obtained: those that made RCS improvement (n = 75) and those that did not (n = 220). 
The full model was not significant and accounted for only 4.9% of variance (Nagelkerke 
R2) χ2(n=295) = 3.3, df = 7, p >.05. 
Psychological distress (K10)  
There were 258 complete admission and discharge datasets available for analysis 
for the K-10. The RCI on the K-10 was 6.9 (rounded to 7).  Using this RCI, 83 of the 
258 patients (32.2%) were designated as reliably improved and 18 patients (7.0%) 
showed reliable deterioration. The remaining participants showed no reliable change. 
Cut-off 2 was calculated as 24.3. Given this cut-off is higher than the mean of 
admission scores of patients on the K-10 this was not seen as a useful cut-off. Cut-off 3 
was calculated as 16.6 (rounded to 17). RCS improvement was made by 52 of 258 
patients (20.2%). RCS deterioration occurred for 12 patients (4.7%).  
Cut-off 3 was selected for the logistic regression and the following groups were 
obtained: those that made RCS improvement (n = 52) and those that did not (n = 94). 
The full model was not significant and accounted for 9.3% of variance (Nagelkerke R2) 
χ2(n=146) = 10.2, df = 7, p >.05.  
Discussion 
The reliable change indices (RCI) suggest that between 32% and 49% of 
patients make improvement. Further, between 20% and 32% of the patients make both 
reliable and clinically significant (RCS) improvements across the three outcome 
measures (using cut-off 3). The RCS method is considered a conservative estimate of 




change [29] and in the context of the current study these rates of improvement may be 
an underestimate given the most recent 3-month review data were used when discharge 
ratings were not available (up to 18% of cases). 
Whilst deterioration was generally infrequent, it occurred most on the 
psychological distress measure. Anecdotal observations suggest that for some patients 
this may occur as a result of increased stress associated with discharge and transition 
back into the community.  
When compared to the Murugesan et al., (2007) study, which was conducted in 
the same treatment facility, there were similar rates of RCS improvement (range 21% to 
33% using cut-off 3). Despite the current study having a larger and more diagnostically 
diverse group of patients, RCS improvement rates were very similar on the measures of 
psychiatric symptomatology and psychological distress. Rates of improvement have 
previously been reported on the HoNOS using the RCI for a large sample (n = 21,749) 
of adults attending public sector acute inpatient settings across Australia (Burgess et al., 
2009). Using the same criteria as in our study for calculating RCI it was found that 38% 
of admission to discharge pairs made improvement. In ambulatory settings only 11.9% 
of the 10,354 admission to discharge pairs improved using the RCI. In our study the 
equivalent improvement rate using the RCI was 30.4%.  
The use of the same performance indicators facilitates comparisons between 
areas. Whether this rate of improvement is “satisfactory”, likely depends on the 
perspective of different stakeholders. Individuals attending this inpatient setting have 
usually exhausted the capacity of public sector acute inpatient services. It is often these 
units that refer to the longer stay facilities. Patients are clearly seen as being in need of 
further treatment (and supervision) which cannot be provided by other shorter term 




services. Around 25% make clinically meaningful improvement which potentially 
increases their capacity to live in less restrictive environments in the community. For 
these individuals and their families such outcomes are likely to be viewed positively. 
Whether this is “good value for money” can not be determined from our study. Such 
questions would ideally be addressed through randomised clinical trials where those 
referred to medium term treatment are compared to other forms of rehabilitation (e.g., 
intensive outpatient services). 
Sizeable groups appeared to be “asymptomatic” on the measures at admission 
when compared to normative samples (HoNOS, 10%; BPRS-E, 25%; K10, 43%).  As a 
result these participants could not be included in regression analyses that predicted RCS 
improvements because by definition they cannot attain this change (Bowersox et al., 
2009). Whether participants appear asymptomatic depends on the normative comparison 
group and the outcome variable. For example, the asymptomatic rate for the K10 is 
relatively high, but psychological distress is more of a state versus trait construct, and is 
relatively transient, thus ratings are likely to vary dependent on recent experiences. 
Many patients may not be experiencing acute levels of distress at the time they come 
into hospital and to some extent these ratings will depend on how long they have been 
in hospital before the intake assessment is completed. In the case of the BPRS-E, the 
normative comparison group was a sample of patients still receiving treatment but on an 
outpatient basis in the community. Although they could be considered a more 
“functional” group overall, they are still likely to be experiencing significant psychiatric 
symptoms. Thus, some in our inpatient sample are likely to appear “asymptomatic” in 
comparison. It is also possible that some individuals are experiencing specific 
behavioural difficulties (e.g., self harm) that mean overall ratings on the measures are 




not elevated (only specific items). Finally, it is possible that an individual could be 
considered asymptomatic on one measure, but not on another. Having low levels of 
severity in one domain (e.g. psychological distress) does not necessarily mean that there 
is good mental health overall.  
In addition to determining rates of improvement, a question of equal or more 
importance is how might we begin to increase the proportion of people who improve? A 
step in this direction involves understanding which factors are related to improvement. 
Burgess et al., (2009) argue that, “Expectations of change will also vary within settings, 
depending on individual person-based factors such as diagnosis, level of severity of 
presenting symptoms and so on”, (p. 537). Our study is one of the first to determine 
whether some of the person-based factors are related to RCS change amongst inpatients. 
Regression analyses indicated that for psychiatric symptomatology, a significantly 
higher proportion of patients with schizoaffective disorder made RCS improvement 
relative to those with schizophrenia. This finding is consistent with other research 
indicating a more favourable prognosis for people with schizoaffective disorder (Walker 
et al., 2004). However, it is unclear why this was only found for psychiatric 
symptomatology and not other outcome domains. Firstly, the relationships between the 
BPRS-E and other outcome measures at intake and discharge were small to moderate (r 
< .26). Thus, they appear to be capturing different outcome domains which could 
account for variable prediction. As noted, the transient nature of psychological distress 
(K10) may mean that prediction is less reliable using relatively static variables such as 
diagnosis. With regard to psychosocial functioning, the HoNOS captures a broad range 
of behavioural and social domains but several of the items are unlikely to show any 
variability within an inpatient setting (e.g., problems with occupation and activities, 




problems with living condition). A lack of variability and low sensitivity to change has 
led others to conclude that the “HoNOS is severely limited in its ability to detect and 
record clinically meaningful change” (p. 565) at least in outpatient psychological 
treatment (Audin et al., 2001). All of these factors may have contributed to difficulty in 
finding reliable predictors on these measures.  
Given, some of the logistic regression analyses did not predict RCS change, 
further research should examine other potential predictors of RCS change. For example, 
there is some evidence to suggest that neurocognitive deficits may be related to outcome 
(Green et al., 2000). In addition, more dynamic treatment variables such as medication 
adherence or participation in other treatment activities may prove fruitful for predicting 
outcomes in the future. 
The presence of a comorbid diagnosis of substance abuse approached 
significance for predicting RCS changes in psychiatric symptomatology. The superior 
improvement rates for those with a comorbid diagnosis of a substance use disorder are 
most likely a function of reduced access to alcohol and drugs as a result of being in 
residential treatment. The result is notable because treatment outcomes for those with 
comorbid substance abuse disorders tend to be poor compared to those without 
comorbidity (Turkington et al., 2009).  
There is a need to determine whether these initial benefits whilst in residential 
care are able to be maintained and built upon once individuals are discharged to 
community or less restrictive care. This is particularly important because rates of 
community-based treatment have been found to be lower in those with severe mental 
illness and co-occurring substance use disorder (Clark et al., 2007). Amongst substance 
abusing samples, a comorbid diagnosis of schizophrenia is associated with lower rates 




of attendance in Alcoholics Anonymous compared to those without schizophrenia 
(Tomasson and Vaglum, 1998).  
In our study one third of those with a diagnosis of schizophrenia also had a 
comorbid diagnosis of a substance use disorder. If individuals with severe mental illness 
and comorbid substance use disorders are less likely to engage in outpatient treatment 
they are potentially at higher risk of relapse. A review of relapse in drug and alcohol use 
amongst those with co-occurring mental health and substance use disorders found “no 
studies” had examined such relapse amongst those diagnosed with schizophrenia-
spectrum disorders (Bradizza et al.,  2006). Our more recent search also failed to find 
any studies that report these relapse rates. 
The present study has several limitations. First, a considerable proportion of 
patients were considered asymptomatic according to the cut-off points, indicating a high 
overlap between “functional” populations and the inpatient population. Although 
patients may have low distress scores, they can still have high symptom severity or 
functional deficits. They may be asymptomatic on one measure but this does not 
automatically mean they have “good” overall mental health. Second, while clinical 
significance methods have several advantages, a limitation of using this method is the 
lack of appropriate normative data (Lambert and Ogles, 2009). Thirdly, it is difficult to 
evaluate the meaning of the RCS rates without a control group or a comparison group 
such as other forms of care.  
Higher proportions of patients with schizoaffective disorders and those with 
comorbid substance use disorders showed RCS improvements in psychiatric 
symptomatology compared to those schizophrenia and those with no comorbid 
diagnosis. This is encouraging given the difficulty in treating comorbidity in outpatient 




settings, but there is an urgent need to follow patients into the community to assess their 
engagement with treatments that address both their mental illness and substance abuse. 
Continued assessment of outcomes and drug and alcohol related relapse would also help 
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BPRS-E 173 (51.3) 70.38 (16.77) 52.32 (13.35)  16.34*** 
HoNOS 329 (97.6) 13.49 (5.96) 6.51 (4.27) 18.98*** 
K-10 258 (76.6) 20.90 (8.81) 16.51 (6.84) 8.67*** 
a Number of complete admission and most recent review/discharge datasets available 
for analysis. BPRS-E, Expanded Brief Psychiatric Rating Scale; HoNOS, Health of 






Binary logistic regression predicting reliable and clinically significant (RCS) 
improvement on psychiatric symptomatology (BPRS-E cutoff 2)  
 
Note. * p < .05. ^ p = .053, Dependent variable is 0 = no RCS improvement 1 = RCS 
improvement. 10 = female, 1 = male. 2 Schizophrenia is the reference category 3 No 
comorbid diagnosis is the reference category 
Variable β SE of β Exp(β) 
(Odds ratio) 
95% CI 
Age -.02 -.02 .98 (.94, 1.02) 
Gender1 -.61 .41 .54 (.24, 1.22) 
Length of stay (days) -.00 .00 1.00 (.99,1.00) 
Primary diagnosis2     
 Schizoaffective disorder 1.26* .59 3.52 (1.12,11.18) 
 Other diagnosis .39 .86 1.47 (.27,7.95) 
Comorbid diagnosis3     
Substance abuse  .83^ .43 2.29 (.99,5.29) 
Other disorders .01 .77 1.01 (.22,4.60) 
Constant  .93 .93 2.54  
